
TY  - JOUR
TI  - “Abstracts of the 77th Annual Meeting of the Japanese Cancer Association; 2018 Sept 27-29; Osaka, Japan” as Cancer Science, Supplement 2, Vol 109 (2018)
JO  - Cancer Science
JA  - Cancer Sci
VL  - 109
IS  - S2
SN  - 1347-9032
UR  - https://doi.org/10.1111/cas.13904
DO  - doi:10.1111/cas.13904
SP  - 1
EP  - 1444
PY  - 2018
ER  - 

TY  - JOUR
TI  - 2014 ASPHO Abstracts
JO  - Pediatric Blood & Cancer
JA  - Pediatr Blood Cancer
VL  - 61
IS  - S1
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.25032
DO  - doi:10.1002/pbc.25032
SP  - S1
EP  - S104
PY  - 2014
ER  - 

TY  - JOUR
TI  - 2015 Peripheral Nerve Society Biennial Meeting
JO  - Journal of the Peripheral Nervous System
JA  - J Peripher Nerv Syst
VL  - 20
IS  - 2
SN  - 1085-9489
UR  - https://doi.org/10.1111/jns.12129
DO  - doi:10.1111/jns.12129
SP  - 88
EP  - 253
PY  - 2015
ER  - 

TY  - JOUR
TI  - The Japanese Society of Neuropathology
JO  - Neuropathology
VL  - 31
IS  - 3
SN  - 0919-6544
UR  - https://doi.org/10.1111/j.1440-1789.2010.01226.x
DO  - doi:10.1111/j.1440-1789.2010.01226.x
SP  - 309
EP  - 362
PY  - 2011
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Basic and Applied Pathology
VL  - 2
IS  - s1
SN  - 1755-9294
UR  - https://doi.org/10.1111/j.1755-9294.2009.01059.x
DO  - doi:10.1111/j.1755-9294.2009.01059.x
SP  - A1
EP  - A119
PY  - 2009
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Acta Physiologica
JA  - Acta Physiol
VL  - 217
IS  - S708
SN  - 1748-1708
UR  - https://doi.org/10.1111/apha.12712
DO  - doi:10.1111/apha.12712
SP  - 3
EP  - 158
PY  - 2016
ER  - 

TY  - JOUR
TI  - Oral Presentation
JO  - Journal of Diabetes Investigation
VL  - 3
IS  - s1
SN  - 2040-1116
UR  - https://doi.org/10.1111/jdi.12012
DO  - doi:10.1111/jdi.12012
SP  - 79
EP  - 146
PY  - 2012
ER  - 

TY  - JOUR
TI  - Category Index
JO  - Hepatology
JA  - Hepatology
VL  - 64
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.28802
DO  - doi:10.1002/hep.28802
SP  - 1106
EP  - 1117
PY  - 2016
ER  - 

TY  - JOUR
TI  - Abstracts presented at the 45th Annual Meeting of the American Society of Dermatopathology
JO  - Journal of Cutaneous Pathology
VL  - 36
IS  - 1
SN  - 0303-6987
UR  - https://doi.org/10.1111/j.1600-0560.2008.001200.x
DO  - doi:10.1111/j.1600-0560.2008.001200.x
SP  - 104
EP  - 181
PY  - 2009
ER  - 

AU  - Dutta, Anand S.
C7  - pp. 1-80
TI  - Discovery of New Medicines
SN  - 9781405180351
UR  - https://doi.org/10.1002/9781444317800.ch1
DO  - doi:10.1002/9781444317800.ch1
SP  - 1-80
KW  - discovery of new medicines
KW  - understanding disease processes and mechanisms in controlling disease
KW  - severe acute respiratory syndrome (SARS)
KW  - new infectious diseases - hepatitis C, human herpes virus-6, -7 and -8 and bird flu (H5N1 virus)
KW  - underlying causes of diseases - selective and less toxic drugs
KW  - market needs and changing disease patterns
KW  - new technology impact on drug discovery
KW  - combinatorial chemistry and high-throughput screening
KW  - enzymes and enzyme inhibitors
KW  - DNA and RNA based therapeutics
PY  - 2009
AB  - Summary This chapter contains sections titled: Introduction Market needs and changing disease patterns Medicines marketed in the years 2004?2007 Historical aspects Impact of new technology on drug discovery Examples of drug discovery Enzymes and enzyme inhibitors Protein?protein interaction inhibitors Protein antibody and vaccine therapeutics DNA and RNA based therapeutics Conclusions References
ER  - 

TY  - JOUR
TI  - Wednesday, 27 July 2011
JO  - Journal of Thrombosis and Haemostasis
VL  - 9
IS  - s2
SN  - 9781405180351
UR  - https://doi.org/10.1111/j.1538-7836.2011.04380_3.x
DO  - doi:10.1111/j.1538-7836.2011.04380_3.x
SP  - 499
EP  - 711
PY  - 2011
ER  - 

TY  - JOUR
TI  - American Epilepsy Society Proceedings
JO  - Epilepsia
VL  - 43
IS  - s7
SN  - 9781405180351
UR  - https://doi.org/10.1046/j.1528-1157.43.s7.1.x
DO  - doi:10.1046/j.1528-1157.43.s7.1.x
SP  - 1
EP  - 351
PY  - 2002
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Pain Practice
JA  - Pain Pract
VL  - 16
IS  - S1
SN  - 9781405180351
UR  - https://doi.org/10.1111/papr.12451
DO  - doi:10.1111/papr.12451
SP  - 6
EP  - 176
PY  - 2016
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Internal Medicine Journal
VL  - 40
IS  - s1
SN  - 9781405180351
UR  - https://doi.org/10.1111/j.1445-5994.2010.02187.x
DO  - doi:10.1111/j.1445-5994.2010.02187.x
SP  - 66
EP  - 185
PY  - 2010
ER  - 

TY  - JOUR
TI  - Poster Presentation with Discussion
JO  - European Journal of Neurology
JA  - Eur J Neurol
VL  - 22
IS  - S1
SN  - 9781405180351
UR  - https://doi.org/10.1111/ene.12807
DO  - doi:10.1111/ene.12807
SP  - 120
EP  - 482
PY  - 2015
ER  - 

TY  - JOUR
TI  - Poster Session 2
JO  - International Journal of Gynecological Cancer
VL  - 16
IS  - s3
SN  - 9781405180351
UR  - https://doi.org/10.1111/j.1525-1438.2006.00739.x
DO  - doi:10.1111/j.1525-1438.2006.00739.x
SP  - 695
EP  - 763
PY  - 2006
ER  - 

TY  - JOUR
TI  - Poster Session A
JO  - Acta Physiologica
JA  - Acta Physiol
VL  - 219
IS  - S711
SN  - 9781405180351
UR  - https://doi.org/10.1111/apha.12869
DO  - doi:10.1111/apha.12869
SP  - 70
EP  - 116
PY  - 2017
ER  - 

TY  - JOUR
TI  - Poster Session Abstracts
JO  - Pediatric Pulmonology
JA  - Pediatr. Pulmonol.
VL  - 42
IS  - S30
SN  - 9781405180351
UR  - https://doi.org/10.1002/ppul.20700
DO  - doi:10.1002/ppul.20700
SP  - 202
EP  - 412
PY  - 2007
ER  - 

TY  - JOUR
AU  - Narumiya, Shuh
AU  - Thumkeo, Dean
TI  - Rho signaling research: history, current status and future directions
JO  - FEBS Letters
JA  - FEBS Lett
VL  - 592
IS  - 11
SN  - 9781405180351
UR  - https://doi.org/10.1002/1873-3468.13087
DO  - doi:10.1002/1873-3468.13087
SP  - 1763
EP  - 1776
KW  - actin
KW  - actomyosin
KW  - C3 exoenzyme
KW  - myosin
KW  - Rho
KW  - ROCK
KW  - SRF
KW  - Y-27632
PY  - 2018
AB  - One of the main research areas in biology from the mid-1980s through the 1990s was the elucidation of signaling pathways governing cell responses. These studies brought, among other molecules, the small GTPase Rho to the epicenter. Rho signaling research has since expanded to all areas of biology and medicine. Here, we describe how Rho emerged as a key molecule governing cell morphogenesis and movement, how it was linked to actin reorganization, and how the study of Rho signaling has expanded from cultured cells to whole biological systems. We then give an overview of the current research status of Rho signaling in development, brain, cardiovascular system, immunity and cancer, and discuss the future directions of Rho signaling research, with emphasis on one Rho effector, ROCK*. *The Rho GTPase family. Rho family GTPases have now expanded to contain 20 members. Amino acid sequences of 20 Rho GTPases found in human were aligned and the phylogenetic tree was generated by ClustalW2 software (EMBL-EBI) based on NJ algorithm. The subfamilies of the Rho GTPases are highlighted by the circle and labeled on the right side. Rho cited in this review refers to the original members of Rho subfamily, RhoA, RhoB and RhoC, that are C3 substrates, and, unless specified, not to other members of the Rho subfamily such as Rac, Cdc42, and Rnd.
ER  - 

TY  - JOUR
TI  - Poster Sessions Wednesday/Thursday
JO  - Journal of Neurochemistry
JA  - J. Neurochem.
VL  - 134
IS  - S1
SN  - 9781405180351
UR  - https://doi.org/10.1111/jnc.13189
DO  - doi:10.1111/jnc.13189
SP  - 243
EP  - 382
PY  - 2015
ER  - 
